Page 8 - Demo

For all your livestock needs
Provides high quality products. Delivered on time. At competitive pricing. Supported by the best available technical service in animal and livestock nutrition.
Ph: 02 9609 7922 Fax: 02 9609 7923
Kym Miller 0439 066 054 kym@nationalfeedsolutions.com.au
Ben Hawkes 0400 369 693 ben@nationalfeedsolutions.com.au
Graeme Pope 0439 066 006 graeme@nationalfeedsolutions.com.au
Suppliers of Elite nutrition and solutions
www.nationalfeedsolutions.com.au
NEW Direct Drive EC energy efficient tunnel fans now available in 48” and 54”
NEW ENERGY EFFICIENT DIRECT DRIVE RETROFIT OPTION FOR YOUR EXISTING 48” & 54” MODELS
Visit Titan at the Metrowest stand Booth 41 & 62
YOUR EXISTING TITAN FANS!
STANDARD FITTED WITH
YOUR EXISTING TITAN
NEW energy efficient direct drive retrofit NEW ENERGY EFFICIENT DIRECT DRIVE RETROFIT OPTION
RETROFIT
FANS!
Air Circulator Fan
Retrofit your existing Titan fans! DIRECT DRIVE
AC MOTOR
FH800/0.37kW/4B/1 Phase Part Number: PF6010
C/w - Electrical optionFfOoRr YyOoUuRr EeXxIiSsTtIiNnGg4488” &” a54n”dM5O4D”ELmS odels Actuator Louvre
VARIABLE SPEED
STANDARD: RETROFIT:
Fitted with AC Motor V
Control
Va
peed direct drive
a
r
ri
ia
ab
b
l
le
es
sp
STANDARD
FITTED WITH AC MOTOR
RETROFIT
VARIABLE SPEED DIRECT DRIVE
 HIGH CAPACITY
 Combining an EC Motor with Titan’s Extremely
 No need for Expensive Shed Alterations!  HIGH CAPACITY
C/w - Electrical Actuator Louvre Control
 Direct Drive – Less Maintenance
• Airflow: 9,300 c.f.m. • No need for expensive shed alterations • Direct drive – less maintenance
C/w - Electrical Actuator Louvre Control
SPENCoIFnIeCeAdTfoIOr ENxpSe:nsive Shed Alterations!
• Diameter: 820mm
• High capacity
 Combining an EC Motor with Titan’s Extremely  Direct Drive – Less Maintenance •MEoftofirc:i0e.n3t7BklWad,e9T0e0cRh.Pn.Mol.ogy •CombininganECmotorwithTitan’s •Nobelts,nopulleysandno
 No Belts, No Pulleys and No Centrifugal System • All GRP impeller eEfxfitcriemnteBlyadefTfiecihennoltobgylade technology  No Bceltns,trNifouPguallelysyasntedmNo Centrifugal System
 Variable Speed Integral In Motor  Quick Turnaround Time, Combined with High
• HDG galvanised casing with • VarriaiablbelSepesepdeIentdegirnatleIngMraoltoinr motor  Q•uicQk TuuircnkartouurndaTriomuen, Cdomtimbinee,dcwoitmh bHignhed
safety guards • ElecctrtriciaclaAlctaucatuoraLtourvrloe uCovnretrocl o(AnCtr2o4l... 240 V) QuawlityithMahtiegrihalsq&uSaulpiteyriomr aCotenrsitarulcstiaond
 Electrical Actuator Louvre Control (AC 24... 240 V) • Quiet operation: 66 dB(A) @ 3m (AC 24... 240 V)
POULTRY FANS AUSTRALIA PTY LTD
Quality Materials & Superior Construction
CONTACT US ON 0409 003 884
superior construction
CONTACT 0411 755 467 FOR MORE
POULTRY FANS
CO
T 0411 755 467 FOR MORE
O
ON
N
NT
TA
AC
CT
AUSTRALIA PTY LTD INFORMATION TODAY!
TODAY FOR MORE INFORMATION!
INFORMATION TODAY!
sales@poultryfansaustralia.com.au
Made Stronger to Last Longer!
The Insight Partners pub- lished the latest research study on the poultry vac- cines market forecast to 2028, surmising that the global poultry vaccines market growth is driven by the increasing preva- lence of diseases in poul- try and increasing demand for healthy poultry food.
Boehringer Ingelheim International GmbH, Zoetis Inc, Ceva Santé Animale, Biovac, Phibro Animal Health Corpora- tion, Hester Biosciences Limited, Venky's India, Dechra Pharmaceuticals PLC, Elanco and Merck Animal Health are among the leading companies in the poultry vaccines mar- ket.
The case was the first outbreak of the H5N8 vi- rus in Saudi Arabia since July 2018.
However, life attenuated vaccine is effective if it shows mild immune re- sponse by growing within the bird.
The poultry vaccines market size is expected to grow from $A2.6 billion in 2021 to $A4 billion by 2028.
Poultry vaccines market worth billions
THE poultry vaccines market size is expected to grow from $A2.6 billion in 2021 to $A4 billion by 2028 – it is estimated to grow at a compound annual growth rate of 6.4 from 2021 percent to 2028.
However, the failure of the poultry vaccines im- munisation hampers the market growth.
In January 2020, Boehringer Ingelheim launched Vaxxitek HVT+IBD+ND.
The emergence occurred in the Central Sudair re- gion and killed 22,700 birds.
by weakening the pure cultures of infectious mi- crobes, usually by cultur- ing the pathogen in the laboratory until it loses or reduces its ability to cause a disease and then provid- ing a small dose of these inactivated organisms dur- ing vaccination.
Poultry vaccines market competitive landscape and key developments
The vaccine provides a strong immune foundation and optimised protection against Marek's disease, infectious bursal disease (classic and variant types) and Newcastle disease.
The other 385,300 birds in the flock were slaugh- tered.
In October 2020, Pro- BioGen AG and Ceva Santé Animale announced an exclusive licence agree- ment between them for the manufacturing of vector- ised poultry vaccines us- ing ProBioGen’s proprie- tary AGE1.CR technology.
Thus, the rising number of various poultry diseases is maximising the demand for vaccines for chickens, thereby boosting the glob- al poultry vaccines market growth.
Live attenuated vaccines come under the most ef- fective vaccine category due to rapid and long-last- ing response, low cost and little allergenicity.
The technology has proved its versatility and value in the animal health sector.
Poultry vaccines assist in averting a specific disease by accelerating the birds’ immune systems to gener- ate antibodies.
Dosage form-based in- sights
In February 2021, Merck Animal Health Intelli- gence formed specialised operating unit that will take its name.
They are essential for poultry disease control and the prevention of viral diseases.
The global poultry vac- cines market, by dosage form, is segmented into liquid vaccines, freeze- dried vaccines and dust powdered vaccines.
Based on the company’s strategic vision for ani- mal health intelligence and data expertise, Merck Animal Health Intelli- gence is a complementary business that specialises in identification, traceability, monitoring solutions and services to help improve animal management and health outcomes.
The uncontrolled spread of diseases due to the lack of vaccination may result in adverse events, such as outbreak in entire poultry flock.
The liquid vaccines seg- ment led the market in 2021 – moreover, it is ex- pected to register the high- est CAGR in the market during the forecast period. Disease-based insights
North America is the largest market for poultry vaccines and the US holds the largest share of the regional market, followed by Canada.
Zoonotic diseases – Newcastle disease and avian influenza – are the major poultry diseases. Poultry vaccines market segmental overview Type-based insights
The market growth in the US is attributed to the increasing cases of zo- onotic diseases in poultry – such as Newcastle dis- ease and avian influenza – a rise in consumption of poultry products and meat, a surge in government sup- port for the research and development activities for veterinary products, and growing technological ad- vancements for manufac- turing new vaccines across the country.
The global poultry vac- cines market, by type, is segmented into broiler, layer and breeder.
The Newcastle disease segment led the market in 2021, however the market for the avian influenza segment is expected to grow at a high CAGR dur- ing the forecast period.
On the other hand, Asia Pacific is expected to reg- ister the highest CAGR in the global poultry vaccines market during 2021–2028.
The majority of breeder vaccines are given during the first 18 weeks after birth – the rearing phase.
The drinking water and spray segment led the market in 2021, and it is expected to register a high CAGR in the market dur- ing the forecast period. End user-based insights
In the year 2020, the French Ministry of Ag- riculture confirmed the infection of highly patho- genic H5N8 avian influ- enza on 6000 ducks from a duck farm in Benesse- Mariamne in Landes.
When the first hatching eggs are collected, it needs high protection, which should last until the end of the egg production cycle. Technology-based in- sights
Based on end user, the global poultry vaccines market is segmented as veterinary hospitals, poul- try vaccination centre and clinics, and poultry farms and hatcheries.
The country had previ- ously detected the H5N8 virus infection among birds sold in three pet shops in mid-November 2020.
The global poultry vac- cines market, by technol- ogy, is segmented into live attenuated vaccines, inac- tivated vaccines, recombi- nant vaccines and others.
The poultry farms and hatchery segment led the market in 2021 – moreo- ver, it is expected to reg- ister a high CAGR in the market during the forecast period.
Moreover, Saudi A rabia reported a highly patho- genic H5N8 avian influ- enza virus outbreak on a poultry farm.
The live attenuated vac- cines segment led the market in 2021, and it is expected to register a high CAGR during the forecast period.
Poultry vaccines help en- hance production levels by controlling the spread of contagious diseases.
The global poultry vac- cines market, by disease, is segmented into infec- tious bronchitis, avian in- fluenza, Marek's disease, infectious bursal disease, Newcastle disease, salmo- nellosis and others.
The breeder segment led the market in 2021, and the market for this segment is expected to grow with a high CAGR during the forecast period.
Avian influenza is a highly contagious viral disease that affects both domestic and wild birds. Route of administration- based insights
For many viral infec- tions, the breeder is first given a live vaccine then given an inactivated booster vaccine four to six weeks later to ensure protection for the entire production cycle.
The global poultry vac- cines market, by route of administration, is seg- mented into drinking wa- ter and spray, intramus- cular, subcutaneous and others.
Attenuated or modified live vaccines are made
Page 8 – National Poultry Newspaper, May 2022
The Insight Partners www.poultrynews.com.au